GLIPR1 and neoplasm: The putative tumour suppressor role of GLIPR1 is further supported by the finding that Glipr1-/- mice had reduced survival due to increased rates of spontaneous malignancy, although tumour development was of late onset (after ~500 days) and incomplete penetrance (~40%) [29].